- Home
- DSWL vs AGEN Comparison
DSWL vs AGEN Comparison
Compare DSWL & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSWL
- AGEN
- Stock Information
- Founded
- DSWL 1987
- AGEN 1994
- Country
- DSWL Macau
- AGEN United States
- Employees
- DSWL N/A
- AGEN N/A
- Industry
- DSWL Plastic Products
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSWL Industrials
- AGEN Health Care
- Exchange
- DSWL Nasdaq
- AGEN Nasdaq
- Market Cap
- DSWL 42.5M
- AGEN 52.6M
- IPO Year
- DSWL 1995
- AGEN 2000
- Fundamental
- Price
- DSWL $2.39
- AGEN $2.94
- Analyst Decision
- DSWL
- AGEN Buy
- Analyst Count
- DSWL 0
- AGEN 4
- Target Price
- DSWL N/A
- AGEN $8.00
- AVG Volume (30 Days)
- DSWL 16.2K
- AGEN 814.8K
- Earning Date
- DSWL 06-20-2025
- AGEN 05-12-2025
- Dividend Yield
- DSWL 9.05%
- AGEN N/A
- EPS Growth
- DSWL 69.42
- AGEN N/A
- EPS
- DSWL 0.65
- AGEN N/A
- Revenue
- DSWL $66,813,999.00
- AGEN $103,463,000.00
- Revenue This Year
- DSWL N/A
- AGEN $4.03
- Revenue Next Year
- DSWL N/A
- AGEN $5.57
- P/E Ratio
- DSWL $3.44
- AGEN N/A
- Revenue Growth
- DSWL N/A
- AGEN N/A
- 52 Week Low
- DSWL $2.04
- AGEN $1.38
- 52 Week High
- DSWL $2.74
- AGEN $19.69
- Technical
- Relative Strength Index (RSI)
- DSWL 46.70
- AGEN 62.99
- Support Level
- DSWL $2.22
- AGEN $2.87
- Resistance Level
- DSWL $2.30
- AGEN $3.16
- Average True Range (ATR)
- DSWL 0.05
- AGEN 0.34
- MACD
- DSWL 0.00
- AGEN 0.02
- Stochastic Oscillator
- DSWL 76.92
- AGEN 64.29
About DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).